Skip to main content

Deciduous Therapeutics

San Francisco, United States

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

$10.0M raised
Dec 2022
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Deciduous Therapeutics

How much funding has Deciduous Therapeutics raised?
Deciduous Therapeutics has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Who are Deciduous Therapeutics's investors?
Deciduous Therapeutics's investors include 8VC, Global Brain Corporation, CRV, Presight Capital, The Longevity Fund.
Where is Deciduous Therapeutics headquartered?
Deciduous Therapeutics is headquartered in San Francisco, United States.
What does Deciduous Therapeutics do?
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
What stage is Deciduous Therapeutics at?
Deciduous Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Deciduous Therapeutics — Funding & Investors." VCBacked, December 31, 2022, https://www.vcbacked.co/company/deciduous-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). Deciduous Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/deciduous-therapeutics
Wikipedia (cite web)
{{cite web |title=Deciduous Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/deciduous-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .